Your browser doesn't support javascript.
loading
Secukinumab efficacy in patients with PsA is not dependent on patients' body mass index.
Pantano, Ilenia; Iacono, Daniela; Favalli, Ennio Giulio; Scalise, Giuseppe; Costa, Luisa; Caso, Francesco; Guggino, Giuliana; Scarpa, Raffaele; Ciccia, Francesco.
Afiliación
  • Pantano I; Department of Precision Medicine, Section of Rheumatology, University della Campania L Vanvitelli, Naples, Italy.
  • Iacono D; Department of Precision Medicine, Section of Rheumatology, University della Campania L Vanvitelli, Naples, Italy.
  • Favalli EG; Department of Rheumatology, Gaetano Pini Institute, Milan, Italy.
  • Scalise G; Department of Precision Medicine, Section of Rheumatology, University della Campania L Vanvitelli, Naples, Italy.
  • Costa L; Department of Clinical and Experimental Medicine, Rheumatology Research Unit, University of Naples Federico II School of Medicine and Surgery, Napoli, Campania, Italy.
  • Caso F; Department of Clinical and Experimental Medicine, Rheumatology Research Unit, University of Naples Federico II School of Medicine and Surgery, Napoli, Campania, Italy.
  • Guggino G; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
  • Scarpa R; Department of Clinical and Experimental Medicine, Rheumatology Research Unit, University of Naples Federico II School of Medicine and Surgery, Napoli, Campania, Italy.
  • Ciccia F; Department of Precision Medicine, Section of Rheumatology, University della Campania L Vanvitelli, Naples, Italy francesco.ciccia@unicampania.it.
Ann Rheum Dis ; 81(3): e42, 2022 03.
Article en En | MEDLINE | ID: mdl-32169970

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Psoriásica / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Artritis Psoriásica / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article País de afiliación: Italia